SCHEMBL30108062

SCHEMBL30108062

COc1ccc2c(c1)nc(Cc1ccncc1)n2-c1cc(-c2ccco2)nc(SC)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
ALDH1A1 P00352 3/20 0.39
THRB P10828 2/20 0.39
POLB P06746 2/20 0.39
HTT P42858 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HPGD P15428 1/20 0.39
ALOX12 P18054 1/20 0.39
PTPN7 P35236 1/20 0.39
RECQL P46063 1/20 0.39
RAB9A P51151 1/20 0.39
BLM P54132 1/20 0.39
MCL1 Q07820 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PDE10A Q9Y233 2/20 0.37
MET P08581 1/20 0.37
ADORA3 P0DMS8 1/20 0.36
ADORA2B P29275 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108066 0.88 ADORA2A (0.44) MAPTALDH1A1THRBPOLBHTT
SCHEMBL30108063 0.86 KDM4E (0.40) MAPTALDH1A1THRBPOLBHTT
SCHEMBL30108034 0.85 ALDH1A1 (0.37) MAPTALDH1A1THRBPOLBHTT
SCHEMBL30107964 0.74 ADORA2A (0.46) METADORA3ADORA2BADORA2AADORA1
SCHEMBL30108043 0.73 ADORA2A (0.41) MAPTALDH1A1THRBPOLBHTT
SCHEMBL30107942 0.73 ADORA2A (0.47) MAPTALDH1A1HTTKDM4EHPGD
SCHEMBL30108002 0.72 ADORA2A (0.37) ADORA2AADORA1CNR2
SCHEMBL30108040 0.64 ALDH1A1 (0.42) MAPTALDH1A1POLBHTTKDM4E
SCHEMBL30107973 0.64 KDM4E (0.46) MAPTALDH1A1THRBPOLBHTT
SCHEMBL30107951 0.64 PTGS1 (0.46) MAPTALDH1A1THRBPOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed